Objective Reviewing the surgical outcome of neonates with critical congenital heart diseases(CHD) in the past five years,to summarize the experiences of the treatment for neonates with critical CHD .Methods From Jan.2009 to Dec.2013,521 neonates with critical CHD were admited,all of them were received surgical treatment.Age ranged from 1day to 28 days, mean(21 ±6) days;weights ranged from 2.1 kg to 3.6 kg, mean(2.8 ±0.5)kg.All the children were received op-eration,and cared in cardiac intensive care unit(CCU) postoperatively.Results 22 cases died after surgery,the hospital mor-tality was 4.2%.68 children were left sternal open after the primary repair;39 children inhaled nitric oxide(NO) for the post-operative pulmonary hypertension;22 children needed peritoneal dialysis for acute renal failure;3 children used extracorporeal membrane oxygenation(ECMO) as circulatory support.Follow-up found 18 cases(12.1%) of TGA occurred supravalvular pul-monary stenosis after the arterial switch operation;12 cases(11.0%) of CoA/VSD&IAA/VSD had recoarctation after the aortic arch reconstruction;7 cases(5.6%) of TAPVD occurred postoperative pulmonary venous obstruction.Conclusion Early in-tervention of neonates with critical CHD has achieved excellent results.The time of operation, surgical techniques, cardiopul-monary bypass techniques and perioperative management are key factors to improve the outcome of critical CHD .

Parkinson's disease （PD） is a progressive chronic neurodegenerative disorder with a complex pathogenesis involving oxidative stress， neuroinflammation， mitochondrial dysfunction， and other factors. Currently， the clinical treatment of PD mainly includes levodopa， dopamine receptor agonists， monoamine oxidase B inhibitors， catechol-O-methyltransferase inhibitors， and anticholinergic drugs， but there is a lack of disease-modif g therapies that can definitively improve disease progression. According to the understanding of traditional Chinese medicine （TCM）， PD is characterized by asthenia in origin and sthenia in superficiality. It is primarily caused by liver-kidney Yin deficiency， Qi-blood insufficiency， and closely related to wind， fire， phlegm， and blood stasis. Numerous clinical practices have shown that TCM has significant clinical value in the prevention and treatment of PD， the management of motor and non-motor symptoms， and the neuroprotection of dopaminergic neurons. The underlying mechanisms of TCM include antioxidative stress， anti-neuroinflammation， and regulation of mitochondrial dysfunction. This article categorized and summarized the pathogenesis of PD， systematically elucidated the pharmacological actions and molecular mechanisms of TCM monomer extracts and compounds in the prevention and treatment of PD， and provided the latest clinical research progress， aiming to provide references for the development and clinical use of TCM for PD.